diallyl trisulfide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Darling-Reed, SF; Ferguson, DT; Kanga, KJW; Mendonca, P; Soliman, KFA | 1 |
| Chakraborti, A; Kundrapu, DB; Malla, R; Marni, R | 1 |
| Bhuyan, NR; De, A; Dua, K; Ko, YT; Kuppusamy, G; Roychowdhury, P; Singh, SK | 1 |
| Darling-Reed, S; Ferguson, DT; Kanga, KJW; Kanga, LHB; Mendonca, P; Reed, SL; Soliman, KFA | 1 |
| Cao, Y; Chen, J; Chen, W; Liu, Y; Liu, Z; Lu, Y; Ruan, J; Shan, Y; Sheng, X; Tao, L; Wang, A; Wang, S; Wei, Z; Zhao, Y | 1 |
| Cheng, SY; Huang, CY; Kuo, WW; Ting, KL; Viswanadha, VP; Wen, SY; Yang, YC | 1 |
6 other study(ies) available for diallyl trisulfide and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Effect of Diallyl Trisulfide on TNF-α-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells.
Topics: Allyl Compounds; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Survival; Chemokine CCL2; Cytokines; Female; Gene Expression Regulation, Neoplastic; Humans; Sulfides; Triple Negative Breast Neoplasms; Tumor Necrosis Factor-alpha | 2021 |
Insight into drug sensitizing effect of diallyl disulfide and diallyl trisulfide from Allium sativum L. on paclitaxel-resistant triple-negative breast cancer cells.
Topics: Allyl Compounds; Antioxidants; Apoptosis; Cell Line, Tumor; Disulfides; Garlic; Humans; Paclitaxel; Reactive Oxygen Species; Sulfides; Triple Negative Breast Neoplasms | 2022 |
Folic Acid Functionalized Diallyl Trisulfide-Solid Lipid Nanoparticles for Targeting Triple Negative Breast Cancer.
Topics: Allyl Compounds; Apoptosis; Cell Line, Tumor; Humans; Nanoparticles; Sulfides; Triple Negative Breast Neoplasms | 2023 |
Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-α-induced Triple Negative Breast Cancer Cells.
Topics: Allyl Compounds; Apoptosis; Caspases; Cell Line, Tumor; Humans; Sulfides; Triple Negative Breast Neoplasms; Tumor Necrosis Factor-alpha | 2023 |
Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC).
Topics: Allyl Compounds; Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Disulfides; Female; Humans; Imidazoles; Lymphatic Metastasis; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Protein Binding; RNA Interference; RNA, Small Interfering; Sulfides; Thioredoxins; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Lactate dehydrogenase downregulation mediates the inhibitory effect of diallyl trisulfide on proliferation, metastasis, and invasion in triple-negative breast cancer.
Topics: Allyl Compounds; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carbohydrate Metabolism; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Enzyme Repression; Female; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Neoplasm Metastasis; Sulfides; Triple Negative Breast Neoplasms | 2017 |